ZURICH (Reuters) - The U.S. Food and Drug Administration has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster Enbrel drug, the Swiss ...

Pfizer's deliberations, which previously have not been disclosed, offer a rare window into the frustrating search for Alzheimer's treatments inside one of the world's largest drug companies. Despite ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a biosimilar product in the United States to compete with Amgen's blockbuster Enbrel ...

Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication, through the state’s prescription drug affordability ...

As a physician, I have seen firsthand the challenges and inequities of our health-care system. But nothing prepared me for the experience of navigating it myself while seeking treatment for a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...